Pink Sheet Podcast: US FDA Adcomm Schedule, CMS And Drug Importation, Missed User Fee Goals

Pink Sheet reporters and editors discuss the nearly wide open 2024 FDA advisory committee calendar, CMS’s impact on Florida’s drug importation plan, and the FDA’s many missed user fee goals in 2023.

Pink Sheet podcast
Will CMS policies discourage states from creating drug importation plans? • Source: Citeline/Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers